New data show certain children at higher risk for hospitalization and severe disease.
Videos acknowledge concerns and respect the decision-making power of people with disabilities.
Experience fueled monoclonal antibody development in under a month.
Ongoing study demonstrates majority flagged can safely receive penicillin.
Heart attack and stroke risks rise as cells respond to respiratory infections.
High-throughput approach reveals ultrapotent candidate with efficacy against SARS-CoV-2 variants.
1 / 5
Head of Vanderbilt-led study discusses ongoing research to evaluate SARS-CoV-2 vaccines.
New study will detail role of upper respiratory tract bacteria in susceptibility to SARS-CoV-2.
From drug discovery to health equity, Vanderbilt joins worldwide leaders to conquer the pandemic.